Telemedicine at Five Times Less Cost: What the Data Really Means — and What Providers Must Do Now 

By Oksana Pokoyeva, Billing Department, WCH 

The Numbers at a Glance 

$96 per telemedicine episode vs. $509 in-person 23% fewer follow-up visits for telemedicine patients ~$800 savings on respiratory episodes per episode 4–6% telemedicine’s share of ambulatory visits — still significant headroom 

Source: Penn Medicine, 163,000 visits, Jan–Apr 2024. Published JAMA Network Open, February 2026. 

The Finding That Changes Everything 

For years, telemedicine was treated as a stopgap — useful in a crisis, never fully trusted. The implicit assumption: virtual visits are incomplete, and the patient ends up back in the clinic anyway. 

A February 2026 study from Penn Medicine demolishes that assumption. 

Researchers tracked 163,000 ambulatory visits across 5 hospitals — not just the cost of the first encounter, but everything that happened in the 30 days after: labs, referrals, follow-ups, escalations. They applied propensity score matching to compare like patients. The 5× cost advantage held. 

Telemedicine isn’t deferring care. For the right conditions, it’s resolving it.